Use of rotigotine for the treatment of depression

Details for Australian Patent Application No. 2004258697 (hide)

Owner Schwarz Pharma AG

Inventors Breidenbach, Alexander; Selve, Norma; Scheller, Dieter

Agent Davies Collison Cave

Pub. Number AU-B-2004258697

PCT Pub. Number WO2005/009424

Priority 103 34 188.9 26.07.03 DE

Filing date 22 July 2004

Wipo publication date 3 February 2005

Acceptance publication date 1 October 2009

International Classifications

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/381 (2006.01) - having five-membered rings

Event Publications

16 March 2006 PCT application entered the National Phase

  PCT publication WO2005/009424 Priority application(s): WO2005/009424

1 October 2009 Application Accepted

  Published as AU-B-2004258697

25 November 2010 Alteration of Name

  The name of the applicant has been altered to UCB Pharma GmbH

2 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004258698-Substituted 2-aminotetralin for the treatment of depression

2004258687-Methods for diagnosing and treatment of conditions that alter phosphate transport in mammals